Active	Status	Sponsor type	Region	Phase	Filter
12 Active 3 Inactive 15 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

12 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Anter, Mohamed E
NCT05166668: Letrozole /GnRH Antagonist Protocol in Women Over 40 Years Undergoing ICSI Cycle	Recruiting	N/A	200	RoW	Letrozole 2.5mg tablet, Gonadotropins units	Menoufia University	Ovarian Stimulation	11/22	12/22
NCT05164224: Serum Procalcitonin and Post-cesarean Wound Infection	Recruiting	N/A	64	RoW		Menoufia University	Cesarean Wound Disruption	01/22	03/22
El-Mahdy, Nageh Ahmed
NCT04834557: Evaluating the Effect of Digoxin and Ursodeoxycholic Acid in Patients With Rheumatoid Arthritis	Completed	2	90	RoW	Placebo, Digoxin 0.25 mg, Ursodeoxycholic acid (UDCA) 500 mg	Tanta University	Rheumatoid Arthritis	05/22	09/22
NCT05973370: Evaluating the Effect of Ursodeoxycholic Acid in Patients With Rheumatoid Arthritis	Completed	2	60	RoW	Placebo, Ursodeoxycholic acid (UDCA) 500 mg	Tanta University	Rheumatoid Arthritis	11/23	05/24
Hamid, Medhat Ismail Abdel
NCT04834557: Evaluating the Effect of Digoxin and Ursodeoxycholic Acid in Patients With Rheumatoid Arthritis	Completed	2	90	RoW	Placebo, Digoxin 0.25 mg, Ursodeoxycholic acid (UDCA) 500 mg	Tanta University	Rheumatoid Arthritis	05/22	09/22
NCT05973370: Evaluating the Effect of Ursodeoxycholic Acid in Patients With Rheumatoid Arthritis	Completed	2	60	RoW	Placebo, Ursodeoxycholic acid (UDCA) 500 mg	Tanta University	Rheumatoid Arthritis	11/23	05/24
Seif, Dalia Salah
NCT04834557: Evaluating the Effect of Digoxin and Ursodeoxycholic Acid in Patients With Rheumatoid Arthritis	Completed	2	90	RoW	Placebo, Digoxin 0.25 mg, Ursodeoxycholic acid (UDCA) 500 mg	Tanta University	Rheumatoid Arthritis	05/22	09/22
NCT05973370: Evaluating the Effect of Ursodeoxycholic Acid in Patients With Rheumatoid Arthritis	Completed	2	60	RoW	Placebo, Ursodeoxycholic acid (UDCA) 500 mg	Tanta University	Rheumatoid Arthritis	11/23	05/24
Osman, Enass Yousef
NCT04834557: Evaluating the Effect of Digoxin and Ursodeoxycholic Acid in Patients With Rheumatoid Arthritis	Completed	2	90	RoW	Placebo, Digoxin 0.25 mg, Ursodeoxycholic acid (UDCA) 500 mg	Tanta University	Rheumatoid Arthritis	05/22	09/22
NCT05973370: Evaluating the Effect of Ursodeoxycholic Acid in Patients With Rheumatoid Arthritis	Completed	2	60	RoW	Placebo, Ursodeoxycholic acid (UDCA) 500 mg	Tanta University	Rheumatoid Arthritis	11/23	05/24
Bolous, Mariam George Tadros
NCT04834557: Evaluating the Effect of Digoxin and Ursodeoxycholic Acid in Patients With Rheumatoid Arthritis	Completed	2	90	RoW	Placebo, Digoxin 0.25 mg, Ursodeoxycholic acid (UDCA) 500 mg	Tanta University	Rheumatoid Arthritis	05/22	09/22
NCT05973370: Evaluating the Effect of Ursodeoxycholic Acid in Patients With Rheumatoid Arthritis	Completed	2	60	RoW	Placebo, Ursodeoxycholic acid (UDCA) 500 mg	Tanta University	Rheumatoid Arthritis	11/23	05/24